Sales and results

Novartis provides the following information on the Group's strong financial performance since its creation in 1996.

 

 

Financial results ›
View recent and archived quarterly results.

 

 

 

SEC filings ›
Use the SEC’s EDGAR system to search and review all US disclosure filings by Novartis.

 

 

 

Product sales ›
Explore the virtual body to view sales data of major Novartis products by disease area.

 

 

Selected exchange rate data ›
Find quarterly data on foreign exchange rates for selected currencies - Swiss franc (CHF), euro (EUR), British pound (GBP) and Japanese yen (JPY) compared to the US dollar, the Group's reporting currency.